Literature DB >> 23368696

Effects of exercise on monocrotaline-induced changes in right heart function and pulmonary artery remodeling in rats.

Rafael Colombo1, Rafaela Siqueira, Cristiano Urbano Becker, Tânia Gatelli Fernandes, Karla Maria Pires, Samuel Santos Valença, Maristela Padilha Souza-Rabbo, Alex Sander Araujo, Adriane Belló-Klein.   

Abstract

Pulmonary arterial hypertension (PAH) induced by monocrotaline (MCT) is an experimental protocol of right heart failure. We analyzed the role of exercise training on the right ventricle structure and function, pulmonary artery remodeling, and GSK-3β expression. Rats were divided among the following groups: sedentary control (SC), sedentary monocrotaline (SM), trained control (TC), and trained monocrotaline (TM). Rats underwent exercise training for a period of 5 weeks, with 3 weeks post-MCT injection. Rats in the SM and TM groups presented with an increase in right ventricle hypertrophy indexes and lung congestion. The right ventricular end diastolic pressure (RVEDP), right ventricular systolic pressure (RVSP), and its minimum and maximal pressure derivates were increased in the SM and TM groups. The right ventricle interstitial volume pulmonary artery thickness and p-GSK-3β/GSK-3β were increased in the MCT groups as compared with the control groups. The TM group had a reduction in interstitial volume, p-GSK-3β/GSK-3β ratio, pulmonary artery thickness, RVEDP, and an increase in intramyocardial vessels volume as compared with the SM group. The overall results have shown that the exercise protocol used promoted positive changes in right ventricle and pulmonary artery remodeling. These observations also suggest that structural remodeling may be influenced by signaling proteins, such as GSK-3β.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23368696     DOI: 10.1139/cjpp-2012-0261

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  11 in total

1.  Severe pulmonary arterial hypertensive rats are tolerant to mild exercise.

Authors:  Leslie A Hargett; Lauren J Hartman; April K Scruggs; Jared M McLendon; April K Haven; Natalie N Bauer
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

2.  Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension.

Authors:  A Zimmer; R B Teixeira; J H P Bonetto; R Siqueira; C C Carraro; L M Donatti; A Hickmann; I E Litvin; A E G Godoy; A S Araujo; R Colombo; Adriane Belló-Klein
Journal:  Mol Cell Biochem       Date:  2017-02-08       Impact factor: 3.396

3.  Secoisolariciresinol diglucoside attenuates cardiac hypertrophy and oxidative stress in monocrotaline-induced right heart dysfunction.

Authors:  Stephanie Puukila; Rafael Oliveira Fernandes; Patrick Türck; Cristina Campos Carraro; Jéssica Hellen Poletto Bonetto; Bruna Gazzi de Lima-Seolin; Alex Sander da Rosa Araujo; Adriane Belló-Klein; Douglas Boreham; Neelam Khaper
Journal:  Mol Cell Biochem       Date:  2017-03-20       Impact factor: 3.396

4.  Resistance Exercise Training Mitigates Left Ventricular Dysfunctions in Pulmonary Artery Hypertension Model.

Authors:  Leôncio Lopes Soares; Luciano Bernardes Leite; Luiz Otávio Guimarães Ervilha; Bruna Aparecida Fonseca da Silva; Maíra Oliveira de Freitas; Alexandre Martins Oliveira Portes; Leonardo Mateus Teixeira Rezende; Filipe Rios Drummond; Miguel Araújo Carneiro-Júnior; Mariana Machado Neves; Emily Correna Carlo Reis; Antônio José Natali
Journal:  Arq Bras Cardiol       Date:  2022-09-02       Impact factor: 2.667

5.  Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Katashi Okoshi; Thaoan Bruno Mariano; Dijon Henrique Salomé Campos; Robson Francisco Carvalho; Antônio Carlos Cicogna; Luiz Carlo Marques Vanderlei
Journal:  Int J Exp Pathol       Date:  2016-07-01       Impact factor: 1.925

Review 6.  The benefit of exercise-based rehabilitation programs in patients with pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Lu Yan; Wence Shi; Zhihong Liu; Zhihui Zhao; Qin Luo; Qing Zhao; Qi Jin; Yi Zhang; Xin Li; Anqi Duan
Journal:  Pulm Circ       Date:  2021-05-27       Impact factor: 3.017

7.  Exercise Training Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Stenosis.

Authors:  Brunno Lemes de Melo; Stella S Vieira; Ednei L Antônio; Luís F N Dos Santos; Leslie A Portes; Regiane S Feliciano; Helenita A de Oliveira; José A Silva; Paulo de Tarso C de Carvalho; Paulo J F Tucci; Andrey J Serra
Journal:  Front Physiol       Date:  2016-12-05       Impact factor: 4.566

8.  Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.

Authors:  Nicola Ehlken; Mona Lichtblau; Hans Klose; Johannes Weidenhammer; Christine Fischer; Robert Nechwatal; Sören Uiker; Michael Halank; Karen Olsson; Werner Seeger; Henning Gall; Stephan Rosenkranz; Heinrike Wilkens; Dirk Mertens; Hans-Jürgen Seyfarth; Christian Opitz; Silvia Ulrich; Benjamin Egenlauf; Ekkehard Grünig
Journal:  Eur Heart J       Date:  2015-07-31       Impact factor: 29.983

9.  Fractal Dimension in Quantifying Experimental-Pulmonary-Hypertension-Induced Cardiac Dysfunction in Rats.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Thaoan Bruno Mariano; Guilherme Akio Tamura Ozaki; Robson Chacon Castoldi; Edna Maria do Carmo; Robson Francisco Carvalho; Loreta Casquel Tomasi; Katashi Okoshi; Luiz Carlos Marques Vanderlei
Journal:  Arq Bras Cardiol       Date:  2016-05-24       Impact factor: 2.000

10.  Effectiveness and safety of exercise training and rehabilitation in pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Xiaomei Zeng; Haiming Chen; Honglian Ruan; Xiaojuan Ye; Jieying Li; Cheng Hong
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.